PLANNING AND EVALUATION Planning and Evaluation is a critical component of a complex program such as this tripartite partnership between MSM, TU and the UABCCC. Planning and evaluation has been an integral part of the current Partnership between our institutions under the U56 and P20 mechanism. However, some modifications in the planning and evaluation process have been made to meet the needs of the U54 Partnership and are outlined/described in this section. a. Internal Activities Planning and evaluation is the ultimate responsibility of the Pis from each partner institution and will be carried out administratively with the advice, guidance and direction of the Partnership Internal Advisory Committee (IAC) and the Program Steering Committee (PSC). These latter two groups will provide planning and evaluation for the overall Partnership activities that are designed to achieve the goals and objectives of the Partnership as stated in Section 1.1. The IAC will be supported at the institutional level by the Executive Committees of UAB, MSM and TU respectively. As noted in the Administrative Core, Section I.6., these committees are responsible for oversight of the Partnership's activities at the institutional level and are composed of the same individuals that make up the IAC. The Partnership IAC will meet monthly via teleconference and at least quarterly face-to-face. We have used this meeting frequency (teleconference/face-to-face) with success over the past six and a half years under the U56/P20/U54 mechanisms. Videoconference capability is in place between MSM, TU and the UABCCC. Videoconferencing of IAC meetings will be implemented in place of teleconference when possible. We still intend to have quarterly face-to-face meetings. Internal planning is the responsibility of the Administrative Core through the institutional Executive Committees and the Partnership IAC and is thus described in the Administrative Core, Section 1.6. b. External Activities Program Steering Committee The PSC will serve as the external review and evaluation component of the Partnership's Planning and Evaluation Core. New members of the PSC for the U54 resubmission were nominated by investigators from within the existing Partnership. The nominations were based on the expertise that each could bring to the project. We have elected to retain five members of our U56/P20 Program Committee. These individuals have been a valuable resource to the Partnership and have served faithfully in this role. Each has agreed to continue. In addition, we have added four new members who were nominated by investigators and leaders in the U54 application (see below). These new members were carefully chosen in order to fill identified gaps in expertise on our PSC. We now have a diverse group that will allow an evaluation from many different perspectives and still retain the """"""""corporate history"""""""" of the U56/P20 by having five members from the previous Partnerships (U56/P20) continue. The PSC is comprised of basic, clinical and cancer prevention and control scientists and includes expertise in research, training and career development, bioethics, education and administration.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA118638-05
Application #
8133419
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2010-09-01
Budget End
2011-08-31
Support Year
5
Fiscal Year
2010
Total Cost
$156,429
Indirect Cost
Name
Morehouse School of Medicine
Department
Type
DUNS #
102005451
City
Atlanta
State
GA
Country
United States
Zip Code
30310
Akintobi, Tabia Henry; Lockamy, Elise; Goodin, Lisa et al. (2018) Processes and Outcomes of a Community-Based Participatory Research-Driven Health Needs Assessment: A Tool for Moving Health Disparity Reporting to Evidence-Based Action. Prog Community Health Partnersh 12:139-147
Luo, Yanzhuo; Li, Bingjin; Zhang, Guangxin et al. (2018) Integrated Oncogenomic Profiling of Copy Numbers and Gene Expression in Lung Adenocarcinomas without EGFR Mutations or ALK Fusion. J Cancer 9:1096-1105
Sims, Alexis; Archie-Booker, Elaine; Waldrop, Reinetta T et al. (2018) Factors Associated with Human Papillomavirus Vaccination among Women in the United States. ARC J Public Health Community Med 3:6-12
Davis, Melissa; Tripathi, Shweta; Hughley, Raymond et al. (2018) AR negative triple negative or ""quadruple negative"" breast cancers in African American women have an enriched basal and immune signature. PLoS One 13:e0196909
Ward, Ashley B; Mir, Hina; Kapur, Neeraj et al. (2018) Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways. World J Surg Oncol 16:108
Singh, Santosh Kumar; Mishra, Manoj K; Eltoum, Isam-Eldin A et al. (2018) CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells. Sci Rep 8:1323
Puri, Pawan; Schaefer, Caitlin M; Bushnell, Daniel et al. (2018) Ectopic Phosphorylated Creb Marks Dedifferentiated Proximal Tubules in Cystic Kidney Disease. Am J Pathol 188:84-94
Nguyen, Thu-Cuc; Bajwa, Ravneet; Bari, Shahla et al. (2018) Stereotactic body radiation therapy for the treatment of oligoprogression on androgen receptor targeted therapy in castration-resistant prostate cancer. Oxf Med Case Reports 2018:omx078
Akinyemiju, Tomi; Moore, Justin Xavier; Pisu, Maria et al. (2018) A Prospective Study of Obesity, Metabolic Health, and Cancer Mortality. Obesity (Silver Spring) 26:193-201
Chowdhury, Indrajit; Banerjee, Saswati; Driss, Adel et al. (2018) Curcumin attenuates proangiogenic and proinflammatory factors in human eutopic endometrial stromal cells through the NF-?B signaling pathway. J Cell Physiol :

Showing the most recent 10 out of 114 publications